Published in
Taylor and Francis Group, Leukemia & Lymphoma, 9(43), p. 1803-1806
DOI: 10.1080/1042819021000006448
Links
Tools
Oral Cyclophosphamide Therapy for Patients with Residual or Relapsed Indolent-Type Lymphoma after Initial Treatment for Aggressive Lymphomas. A Sub-group of Patients with Apparent Transformed Indolent Lymphoma
Journal article published in 2002 by
R. Riccioni,
S. Galimberti,
G. Cervetti,
R. Fazzi,
F. Caracciolo 
,
M. Petrini
,
M. Petrini
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 